z-logo
open-access-imgOpen Access
Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy
Author(s) -
Yong Luo,
Xiaopeng Liu,
Jingbo Lin,
Weide Zhong,
Qing-Biao Chen
Publication year - 2022
Publication title -
mathematical biosciences and engineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.451
H-Index - 45
eISSN - 1551-0018
pISSN - 1547-1063
DOI - 10.3934/mbe.2022528
Subject(s) - nomogram , gene signature , prostate cancer , oncology , immunotherapy , immune system , proportional hazards model , receiver operating characteristic , medicine , biochemical recurrence , breakpoint cluster region , biology , cancer , immunology , gene expression , gene , genetics , receptor , prostatectomy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom